Reversal by K-agonists of peritoneal irritation-induced ileus and visceral pain in rats

Life Sciences

Volumn 60, Issue 9, 1997, Pages 625-634

  Friese, N ^b   Chevalier, E ^b   Angel, F ^a   Pascaud, X ^b   Junien, J L ^b,c   Dahl, S G ^b   Riviere P J M ^b,d  

^a INSERM   (France)

^b Institut de Recherche Jouveinal   (France)

^c Ferring SA   (France)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

opioid receptor agonist; opioid receptor agonist; digestive ileus; peritoneal irritation; visceral pain

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ACETIC ACID; BREMAZOCINE; CYCLAZOCINE; EDETATE CHROMIUM CR 51; ENADOLINE; FENTANYL; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZO[B]THIOPHENE 4 ACETAMIDE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NORBINALTORPHIMINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ANALGESIC AGENT; BENZOFURAN DERIVATIVE; BENZOMORPHAN DERIVATIVE; DRUG DERIVATIVE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTREXONE; NARCOTIC ANTAGONIST; PYRROLE DERIVATIVE; PYRROLIDINE DERIVATIVE; THIOPHENE DERIVATIVE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ILEUS; INTESTINE TRANSIT TIME; NONHUMAN; PERITONEUM; RAT; STOMACH EMPTYING; SUBCUTANEOUS DRUG ADMINISTRATION; TEST MEAL; VISCERAL PAIN; WRITHING TEST; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; INTESTINE PSEUDOOBSTRUCTION; MALE; PAIN; SPRAGUE DAWLEY RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ACETIC ACID; ANALGESICS; ANIMALS; BENZOFURANS; BENZOMORPHANS; CYCLAZOCINE; FENTANYL; GASTRIC EMPTYING; INTESTINAL PSEUDO-OBSTRUCTION; MALE; MORPHINE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN; PERITONEUM; PYRROLES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; THIOPHENES;

EID: 0030637163     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00647-9     Document Type: Article

References (41)

1. 1. E.H. LIVINGSTON and E.P. PASSARO, Dig. Dis. Sci. 35 121-132 (1990).
2. 2. J.B. FURNESS and M. COSTA, Med. Biol. 52 82-89 (1974).
3. 3. Y. TACHÉ, E. BARQUIST, R.L. STEPHENS and J. RIVIER, J. Gastrointestinal Motility 3 19-25 (1991).
4. 4 V. PLOURDE, H.C. WONG, J.H. WALSH, H.E. RAYBOULD and Y. TACHÉ, Peptides 14 1225-1229 (1993).
5. 5. M. PAIRET and Y. RUCKEBUSCH, J. Pharm. Pharmacol. 41 757-761 (1989).
6. 6. P.J.M. RIVIÈRE, X. PASCAUD, E. CHEVALIER, B. LE GALLOU and J.L. JUNIEN, Gastroenterology 104 724-731 (1993).
7. 7. L. BUENO, J.P. FERRE and Y. RUCKEBUSCH, Dig. Dis. 23 690-695 (1978).
8. 8 R. KOSTER, M. ANDERSON and E.J. DE BEER, Fed. Proc. 18 412 (1959).
9. 9 E. BARQUIST, M. ZINNER, J. RIVIER and Y. TACHÉ, Am. J. Physiol. 262 G616-G620 (1992).
10. 10. P. HOLZER, I.TH. LIPPE and R. AMAN, Neuroscience 48 715-722 (1992).
11. 11. P. HOLZER, I.TH. LIPPE and U. HOLZER-PETSCHE, Gastroenterology 91 360-363 (1986).
12. 12. A. DUBOIS, V.K. WEISE and I.J. KOPIN, Ann. Surg. 178 781-786 (1973).
13. 13. P.J.M. RIVIÈRE, X. PASCAUD, E. CHEVALIER and J.L. JUNIEN, J. Pharm. Exp. Ther. 270 846-850 (1994).
14. 14. B. BONAZ, P.J.M. RIVIÈRE, X. PASCAUD, J.L. JUNIEN and C. FEUERSTEIN, Soc. Neurosci. Abs. 20 960 (1994).
15. 15. B. BONAZ, V. PLOURDE and Y. TACHÉ, J. Comp. Neurol. 349 212-222 (1994).
16. 16. G.A. BENTLEY, S.H. NEWTON and J. STARR, Br. J. Pharmacol. 73 325-332 (1981).
17. 17 J.H. BROADBEAR, S.S. NEGUS, E.R. BUTELMAN, B.R. de COSTA and J. H. WOODS, Psychopharmacology 115 311-319 (1994).
18. 18 F. PORRECA, H.I. MOSBERG, J.R. OMNAAS, T.F. BURKS and A. COWAN, J. Pharm. Exp. Ther. 240 890-894 (1987).
19. 19. F.V. ABBOTT, Eur. J. Pharmacol. 152 93-100 (1988).
20. 20. T. ENDOH, H. MATSUWA, C. TANAKA and H. NAGASE, Arch. int. Pharmacodyn. 316 30-42 (1992).
21. 21. M.A. GIAMBERARDINO, R. VALENTE, P. de BIGONTINA and L. VECCHIET, Pain 61 459-469 (1995).
22. 22. R.J. TALLARIDA and L.S. JACOB, The Dose-Response Relation in Pharmacology, Springer-Verlag, New York (1979).
23. 23. C.J.E. NIEMEGEERS, J.A.A. VAN BRUGGEN and P.A.J. JANSSEN, Arzeim. Forsch. (Drug Res.) 25 1505-1509 (1975).
24. 24. M.J. MILLAN, J. Pharm. Exp. Ther. 251 334-341 (1989).
25. 25. P.S. PORTOGHESE, A.W. LIPKOWSKI and A.E. TAKEMORI, Life Sci. 40 1287-1292 (1987).
26. 26. J. HALEY, S. KETCHUM and A. DICKENSON, Eur. J. Pharmacol. 191 437-446 (1990).
27. 27. J.N. SENGUPTA and G.F. GEBHART, Gastroenterology 108 A686 (1995).
28. 28. A. LANGLOIS, L. DIOP, P.J.M. RIVIÈRE, X. PASCAUD and J.L. JUNIEN, Eur. J. Pharmacol. 271 245-251 (1994).
29. 29 L. DIOP, P.J.M. RIVIÈRE, X. PASCAUD, M. DASSAUD and J.L. JUNIEN, Eur. J. Pharmacol. 257 181-187 (1994).
30. 30. A. BARBER and R. GOTTSCHLICH, Med. Res. Rev. 12 525-562 (1992).
31. 31. D. BESSE, M.C. LOMBARD and J.M. BESSON, Brain Res. 548 287-291 (1991).
32. 32. A. MANSOUR, C.A. FOX , H. AKIL and S.J. WATSON, Trends Neurosci. 18 22-29 (1995).
33. 33. K. MAEKAWA, M. MINAMI, K. YABUUCHI, T. TOYA, Y. KATAO, Y. HOSOI, T. ONOGI and M. SATOH, Neurosci. Lett. 168 97-100 (1994).
34. 34. M.K-H. SCHÄFER, M. BETTE, H. ROMEO, W. SCHWAEBLE and E. WEIHE, Neurosci. Lett. 167 137-140 (1994).
35. 35. D. BAGNOL, A. MANSOUR, H. AKIL and S.J. WATSON, Analgesia 1 264-267 (1995).
36. 36. B. BONAZ, P.J.M. RIVIÈRE, X. PASCAUD, J.L. JUNIEN and C. FEUERSTEIN, Gastroenterology 108 A573 (1995).
37. 37. P.A.J. JANSSEN, C.J.E. NIEMEGEERS and J.G.H. DONY, Arzeim. Forsch. (Drug Res.) 13 502-507 (1963).
38. 38. F. PORRECA, R.B. RAFFA, A. COWAN and R.J. TALLARIDA, Life Sci. 31 1955-1961 (1982).
39. 39. L. MANARA and A. BIANCHETTI, Ann. Rev. Pharmacol. Toxicol. 25 249-273 (1985).
40. 40. R.E. CONDON, V.E. COWLES, W.J. SCHULTE, C.T. FRANTZIDES, J.L. MAHONEY and S.K. SARNA, Ann. Surg. 203 574-581 (1986).
41. 41. H. YUKIOKA, D.G. BOGOD and M. ROSEN, Br. J. Anesth. 59 581-584 (1987).